Claim 70% Off TipRanks This Holiday Season
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Affluent Partners Holdings ( (HK:1466) ) has shared an announcement.
Baijin Life Science Holdings Limited has entered into a strategic cooperation framework agreement with Shanghai Guhuan Medical Equipment Company Limited. This agreement aims to optimize Baijin’s market ecosystem for medical products and stabilize revenue streams by establishing proprietary sales channels. The agreement also involves the potential appointment of Mr. Liang Liang, an experienced professional in the medical cosmetic industry, to lead the Group’s medical business division.
The most recent analyst rating on (HK:1466) stock is a Hold with a HK$0.58 price target. To see the full list of analyst forecasts on Affluent Partners Holdings stock, see the HK:1466 Stock Forecast page.
More about Affluent Partners Holdings
Baijin Life Science Holdings Limited operates in the biotechnology industry, focusing on the development and sales of medical products. The company, through its subsidiary Beijing Baijin Biotechnology Company Limited, aims to establish a sales channel for branded medical products via self-operated stores.
YTD Price Performance: 1.79%
Average Trading Volume: 454,702
Technical Sentiment Signal: Sell
Current Market Cap: HK$508.6M
See more insights into 1466 stock on TipRanks’ Stock Analysis page.